Original Source(s)
Related Content
Engineering a New Generation of Cancer-Fighting Cells
USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies
October 28, 2026
-
3 min
Three Targets, One CAR T Therapy
First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma
October 19, 2026
-
4 min